Skip to main content
VCbacked
Log inGet Started

Solve Therapeutics

Belmont, United States

Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.

$50.4M raised
Dec 2024
Venture - Series Unknown
BiopharmaBiotechnologyHealth CareTherapeutics

Top Investors

General AtlanticDecheng CapitalSurveyor CapitalMatrix Capital Management

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Solve Therapeutics

How much funding has Solve Therapeutics raised?
Solve Therapeutics has raised $50.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
Who are Solve Therapeutics's investors?
Solve Therapeutics's investors include General Atlantic, Decheng Capital, Surveyor Capital, Matrix Capital Management.
Where is Solve Therapeutics headquartered?
Solve Therapeutics is headquartered in Belmont, United States.
What does Solve Therapeutics do?
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.
What stage is Solve Therapeutics at?
Solve Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Solve Therapeutics — Funding & Investors." VCBacked, December 26, 2024, https://www.vcbacked.co/company/solve-therapeutics. Accessed June 11, 2026.
APA
VCBacked. (2024). Solve Therapeutics — Funding & Investors. Retrieved June 11, 2026, from https://www.vcbacked.co/company/solve-therapeutics
Wikipedia (cite web)
{{cite web |title=Solve Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/solve-therapeutics |website=VCBacked |access-date=June 11, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego